Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% |
|
-.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Walter Messier
FOU | Founder | 69 | 01/90/01 |
Steve Warnecke
CEO | Chief Executive Officer | 68 | 01/10/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Warnecke
CEO | Chief Executive Officer | 68 | 01/10/01 |
Mark Boggess
BRD | Director/Board Member | 64 | 01/10/01 |
Founder | 74 | 01/90/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 189,337 | 0 | 0 | 67.35 % |
Stock B | 1 | 6,655,232 | 4,482,324 ( 67.35 %) | 0 | |
Stock C | 0 | 577,063 | 0 | 0 |
Company contact information
![address Evolutionary Genomics, Inc.(FNAM)](https://cdn.zonebourse.com/static/address/120793346.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.99M | |
+34.09% | 52.85B | |
-7.69% | 38.87B | |
+35.48% | 38.24B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-18.72% | 19.9B | |
+36.04% | 13.18B | |
+29.36% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- FNAM Stock
- Company Evolutionary Genomics, Inc.